Search Results - "Bailey, Howard H."

American Society of Clinical Oncology Statement: Human Papillomavirus Vaccination for Cancer Prevention by Bailey, Howard H, Chuang, Linus T, duPont, Nefertiti C, Eng, Cathy, Foxhall, Lewis E, Merrill, Janette K, Wollins, Dana S, Blanke, Charles D

“…American Society of Clinical Oncology (ASCO), the leading medical professional oncology society, is committed to lessening the burden of cancer and as such…”
Get full text

Global Epidemiology, Prevention, and Management of Hepatocellular Carcinoma by Mak, Lung-Yi, Cruz-Ramón, Vania, Chinchilla-López, Paulina, Torres, Harrys A, LoConte, Noelle K, Rice, John P, Foxhall, Lewis E, Sturgis, Erich M, Merrill, Janette K, Bailey, Howard H, Méndez-Sánchez, Nahum, Yuen, Man-Fung, Hwang, Jessica P

“…The incidence rate of hepatocellular carcinoma (HCC) is rising. It is one of the most common cancers worldwide and accounts for substantial morbidity and…”
Get more information

A Phase II Randomized, Double-blind, Presurgical Trial of Polyphenon E in Bladder Cancer Patients to Evaluate Pharmacodynamics and Bladder Tissue Biomarkers by Gee, Jason R, Saltzstein, Daniel R, Kim, KyungMann, Kolesar, Jill, Huang, Wei, Havighurst, Thomas C, Wollmer, Barbara W, Stublaski, Jeanne, Downs, Tracy, Mukhtar, Hasan, House, Margaret G, Parnes, Howard L, Bailey, Howard H

“…We performed a phase II pharmacodynamic prevention trial of Polyphenon E [a green tea polyphenol formulation primarily consisting of epigallocatechin gallate…”
Get full text

A phase I trial of intraperitoneal sustained-release paclitaxel microspheres (Paclimer®) in recurrent ovarian cancer: A Gynecologic Oncology Group study by Armstrong, Deborah K., Fleming, Gini F., Markman, Maurie, Bailey, Howard H.

“…Paclimer® is a biodegradable polymer microsphere formulation containing 10% (w/w) paclitaxel that is designed to provide a sustained-release form of paclitaxel…”
Get full text

Phase II trial of daily oral perillyl alcohol (NSC 641066) in treatment-refractory metastatic breast cancer by Bailey, Howard H., Attia, Steven, Love, Richard R., Fass, Terri, Chappell, Rick, Tutsch, Kendra, Harris, Linda, Jumonville, Alcee, Hansen, Richard, Shapiro, Gary R., Stewart, James A.

“…Purpose Perillyl alcohol (POH) is a naturally occurring lipid with preclinical activity against mammary carcinomas. We conducted a phase II multi-institutional…”
Get full text

Enhancing the bioavailability of resveratrol by combining it with piperine by Johnson, Jeremy J., Nihal, Minakshi, Siddiqui, Imtiaz A., Scarlett, Cameron O., Bailey, Howard H., Mukhtar, Hasan, Ahmad, Nihal

“…Scope: Resveratrol (3,5,4′‐trihydroxystilbene) is a phytoalexin shown to possess a multitude of health‐promoting properties in pre‐clinical studies. However,…”
Get full text

Ototoxicity of Long‐Term α‐Difluoromethylornithine for Skin Cancer Prevention by Chow, Cynthia L., Havighurst, Thomas, Lozar, Taja, Jones, Todd D., Kim, KyungMann, Bailey, Howard H.

“…Objective Evaluate the effects of α‐difluoromethylornithine (DFMO) on hearing thresholds as part of a randomized, double‐blind, placebo‐controlled trial…”
Get full text

Phase II Study of 1α-Hydroxyvitamin D2 in the Treatment of Advanced Androgen-independent Prostate Cancer by LIU, Glenn, WILDING, George, STAAB, Mary Jane, HORVATH, Dorthea, MILLER, Kelly, DRESEN, Amy, ALBERTI, Dona, ARZOOMANIAN, Rhoda, CHAPPELL, Rick, BAILEY, Howard H

“…Purpose: In this single institution Phase II trial, we evaluated the efficacy of the vitamin D analogue, 1α-OH-D 2 , in patients with advanced…”
Get full text

Predictors of Willingness to Participate in Window-of-Opportunity Breast Trials by Wisinski, Kari B, Faerber, Adrienne, Wagner, Stephanie, Havighurst, Thomas C, McElroy, Jane A, Kim, Kyungmann, Bailey, Howard H

“…We conducted a pilot survey to evaluate breast cancer patients' willingness to participate in a preoperative chemoprevention (ie, window-of-opportunity) study…”
Get full text

Non-melanoma skin cancer event rates in a formalized clinical trial setting: considerations for clinical trial design by Lozar, Taja, Kim, Kyungmann, Havighurst, Thomas C., Wood, Gary S., Kolesar, Jill M., Bailey, Howard H.

“…Here we report clinical risk factors and event rates for the development of new non-melanoma skin cancer (NMSC) in a randomized, double-blind,…”
Get full text

Phase I clinical and pharmacokinetic trial of the cyclin-dependent kinase inhibitor flavopiridol by THOMAS, James P, TUTSCH, Kendra D, DRESEN, Amy, WILDING, George, CLEARY, James F, BAILEY, Howard H, ARZOOMANIAN, Rhoda, ALBERTI, Dona, SIMON, Kris, FEIERABEND, Chris, BINGER, Kimberly, MARNOCHA, Rebecca

“…Flavopiridol (NSC 649890) is a synthetic flavone possessing significant antitumor activity in preclinical models. Flavopiridol is capable of inducing cell…”
Get full text

Risk of developing high‐grade squamous intraepithelial lesions or anal cancer after anal condylomata treatment in people living with HIV by Hewitt, Austin, Kawak, Samer, Yang, Qiuyu, Stafford, Linda Cherney, Bailey, Howard H., Striker, Robert, Hayden, Dana M., Sanger, Cristina B.

“…Aim To assess the risk and natural history of developing advanced anal disease after diagnosis of anal condyloma in people living with HIV (PLWH). Methods This…”
Get full text

A phase II randomized placebo‐controlled trial of pomegranate fruit extract in men with localized prostate cancer undergoing active surveillance by Jarrard, David, Filon, Mikolaj, Huang, Wei, Havighurst, Tom, DeShong, Katina, Kim, KyungMann, Konety, Badrinath R., Saltzstein, Daniel, Mukhtar, Hasan, Wollmer, Barbara, Suen, Chen, House, Margaret G., Parnes, Howard L., Bailey, Howard H.

“…Introduction or Objective Men with favorable‐risk prostate cancer (PCa) on active surveillance may benefit from intervention strategies to slow or prevent…”
Get full text

Cancer chemoprevention is not a failure by Adhami, Vaqar Mustafa, Bailey, Howard H, Mukhtar, Hasan

Get full text

Clinical cancer advances 2015: Annual report on progress against cancer from the American Society of Clinical Oncology by Masters, Gregory A, Krilov, Lada, Bailey, Howard H, Brose, Marcia S, Burstein, Harold, Diller, Lisa R, Dizon, Don S, Fine, Howard A, Kalemkerian, Gregory P, Moasser, Mark, Neuss, Michael N, O'Day, Steven J, Odenike, Olatoyosi, Ryan, Charles J, Schilsky, Richard L, Schwartz, Gary K, Venook, Alan P, Wong, Sandra L, Patel, Jyoti D

Get full text

A randomized, double-blind, dose-ranging, pilot trial of piperine with resveratrol on the effects on serum levels of resveratrol by Bailey, Howard H., Johnson, Jeremy J., Lozar, Taja, Scarlett, Cameron O., Wollmer, Barbara W., Kim, KyungMann, Havinghurst, Thomas, Ahmad, Nihal

“…Resveratrol (3,4,5-trihydroxystilbene) is a naturally occurring phytoalexin with purported health-promoting effects, but with limited oral bioavailability. Our…”
Get full text

Phase I Trial of Weekly Paclitaxel and BMS-214662 in Patients with Advanced Solid Tumors by BAILEY, Howard H, ALBERTI, Dona B, THOMAS, James P, MULKERIN, Daniel L, BINGER, Kimberly A, GOTTARDIS, Marco M, MARTELL, Robert E, WILDING, George

“…Purpose: To assess the maximum tolerated dose (MTD), dose-limiting toxicity (DLT), pharmacodynamics, and antitumor activity of continuous weekly-administered…”
Get full text

A phase I study of tivantinib in combination with temsirolimus in patients with advanced solid tumors by Kyriakopoulos, Christos E., Braden, Amy M., Kolesar, Jill M., Eickhoff, Jens C., Bailey, Howard H., Heideman, Jennifer, Liu, Glenn, Wisinski, Kari B.

“…Summary Background A wide variety of human cancers exhibit dysregulated c-Met activity that has implications in oncogenesis. Phosphorylation of c-Met results…”
Get full text

Stress Keratin 17 Is a Predictive Biomarker Inversely Associated with Response to Immune Check-Point Blockade in Head and Neck Squamous Cell Carcinomas and Beyond by Lozar, Taja, Laklouk, Israa, Golfinos, Athena E, Gavrielatou, Niki, Xu, Jin, Flynn, Christopher, Keske, Aysenur, Yu, Menggang, Bruce, Justine Y, Wang, Wei, Grasic Kuhar, Cvetka, Bailey, Howard H, Harari, Paul M, Dinh, Huy Q, Rimm, David L, Hu, Rong, Lambert, Paul F, Fitzpatrick, Megan B

“…Low response rates in immune check-point blockade (ICB)-treated head and neck squamous cell carcinoma (HNSCC) drive a critical need for robust, clinically…”
Get full text

Epidemiologic Factors and Urogenital Infections Associated With Preterm Birth in a Midwestern U.S. Population by Agger, William A., Siddiqui, Danish, Lovrich, Steven D., Callister, Steven M., Borgert, Andrew J., Merkitch, Kenneth W., Mason, Tina C., Baumgardner, Dennis J., Burmester, James K., Shukla, Sanjay K., Welter, Joseph D., Stewart, Katharina S., Washburn, M.J., Bailey, Howard H.

“…To correlate epidemiologic factors with urogenital infections associated with preterm birth. Pregnant women were sequentially included from four Wisconsin…”
Get full text